Bandaru, N.; Bukke, S.P.N.; Pedapati, V.M.D.; Sowjanaya, G.; Suggu, V.S.; Nalla, S.; Dudhe, P.B.; Ezeonwumelu, J.O.C.; Alagbonsi, A.I.; Onohuean, H.
Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications. Drugs Drug Candidates 2025, 4, 22.
https://doi.org/10.3390/ddc4020022
AMA Style
Bandaru N, Bukke SPN, Pedapati VMD, Sowjanaya G, Suggu VS, Nalla S, Dudhe PB, Ezeonwumelu JOC, Alagbonsi AI, Onohuean H.
Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications. Drugs and Drug Candidates. 2025; 4(2):22.
https://doi.org/10.3390/ddc4020022
Chicago/Turabian Style
Bandaru, Nagaraju, Sarad Pawar Naik Bukke, Veera Mani Deepika Pedapati, Gurugubelli Sowjanaya, Vangmai Swaroopa Suggu, Swathi Nalla, Prashik Bhimrao Dudhe, Joseph Obiezu Chukwujekw Ezeonwumelu, Abdullateef Isiaka Alagbonsi, and Hope Onohuean.
2025. "Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications" Drugs and Drug Candidates 4, no. 2: 22.
https://doi.org/10.3390/ddc4020022
APA Style
Bandaru, N., Bukke, S. P. N., Pedapati, V. M. D., Sowjanaya, G., Suggu, V. S., Nalla, S., Dudhe, P. B., Ezeonwumelu, J. O. C., Alagbonsi, A. I., & Onohuean, H.
(2025). Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications. Drugs and Drug Candidates, 4(2), 22.
https://doi.org/10.3390/ddc4020022
